SEC Form 4 · accession 0000899866-17-000109
ALEXION PHARMACEUTICALS, INC. · ALXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David R Brennan
Director
Period of report
May 10, 2017
Accepted (ET)
May 12, 2017 · 6:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899866
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.0001 per shareF1 | May 10, 2017 | A | 2,030 | $0.00 | A | 4,833 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1RSU's will vest 100% on the 1-year anniversary of the grant date.